Moderna coronavirus vaccine doses can be spaced up to six weeks apart but pregnant women should avoid jab, says WHO
Agency’s director of immunisation says clinical trials needed on pregnant women but there is ‘no reason to think there could be a problem’
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Moderna’s Covid vaccine can be given in two doses as much as six weeks apart, the World Health Organisation (WHO) has said.
The WHO's Strategic Advisory Group of Experts on Immunisation, known as Sage, recommended the jab be given at an interval of 28 days but said that could be extended by a further two weeks under exceptional circumstances.
"The main recommendation for the use of this vaccine is that based on the current elements we recommend it should be given in doses of 100 micrograms or 0.5 ml with an interval of 28 days," Alejandro Cravioto, panel chair, told a virtual briefing.
"This interval might be moved to 42 days but the evidence we have does not go behond that time," he said, speaking from Mexico.
Sage also recommended the Moderna vaccine should not be used on pregnant women unless they are health workers or have conditions putting them at high risk.
This was only because clinical trials of the Moderna vaccine were needed on pregnant women, WHO director of immunisation Kate O'Brien said.
"There is no reason to think there could be a problem in pregnancy, we are just acknowledging the data is not there at the moment," she said.
Ms O’Brien added that the WHO was "working with Moderna to go as quickly as possible" to achieve emergency use listing, allowing it to be rolled out more rapidly.
The Geneva-based health agency has given emergency use listing to just one Covid vaccine – the Pfizer BioNTech shot – so far.
On Monday, Moderna said it believed its jab would be effective against new variants that have emerged in the UK and South Africa.
The company said it found no reduction in the antibody response against the variant found in Britain, and against the South African variant it found a reduced response but still believed its two-dose regimen would provide protection.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments